Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter November 28, 2005

Protein microarrays for the diagnosis of allergic diseases: state-of-the-art and future development

Christian Harwanegg and Reinhard Hiller


In the emerging field of Functional Proteomics, protein microarrays are considered to be one of the most promising tools for the simultaneous analysis of the a) abundance, b) function, and c) interaction of proteins on a system-wide scale. Resting on the technological grounds of widely used DNA biochips, the great power of microarray-based miniature solid-phase immunoassays lies in their potential to investigate in parallel large numbers of analyte pairs in a variety of biological samples. Consequently, this has fuelled aspirations that protein microarrays may serve as tools for the high-throughput functional investigation of complete proteomes and, moreover, that they will develop into promising candidates for innovative in-vitro diagnostic (IVD) applications. To date, published examples of protein microarrays for IVD purposes have included tests for allergy, autoimmune and infectious diseases. Here, we discuss recent advancements in the development of protein microarrays for the profiling of IgE antibodies in the diagnosis of Type 1-related allergic diseases.

Corresponding author: Reinhard Hiller, VBC-GENOMICS Bioscience Research LLC, Rennweg 95 B, 1030 Vienna, Austria Phone: +43 1 796 65 72-51, Fax: +43 1 796 65 72-320,


1. Pollack JR, Iyer VR. Characterizing the physical genome. Nat Genet 2002; 32:515–21.10.1038/ng1035Search in Google Scholar

2. de Leon J, Susce MT, Pan RM, Fairchild M, Koch WH, Wedlund PJ. The CYP2D6 poor metabolizer phenotype may be associated with risperidone adverse drug reactions and discontinuation. J Clin Psychiatry 2005; 66:15–27.10.4088/JCP.v66n0103Search in Google Scholar

3. Gygi SP, Rochon Y, Franza BR, Aebersold R. Correlation between protein and mRNA abundance in yeast. Mol Cell Biol 1999; 19:1720–30.10.1128/MCB.19.3.1720Search in Google Scholar

4. Zhu H, Snyder M. Protein chip technology. Curr Opin Chem Biol 2003; 7:55–63.10.1016/S1367-5931(02)00005-4Search in Google Scholar

5. Stoll D, Templin MF, Bachmann J, Joos TO. Protein microarrays: applications and future challenges. Curr Opin Drug Discov Devel 2005; 8:239–52.Search in Google Scholar

6. Ekins R, Chu F, Biggart E. Multispot, multianalyte immunoassay. Ann Biol Clin 1990; 48:655–66.Search in Google Scholar

7. Labaer J, Ramachandran N. Protein microarrays as tools for functional proteomics. Curr Opin Chem Biol 2005; 9:14–9.10.1016/j.cbpa.2004.12.006Search in Google Scholar

8. Gokler J, Angenendt P. Protein and antibody microarray technology. J Chromatogr B Analyt Technol Biomed Life Sci 2003; 797:229–40.10.1016/j.jchromb.2003.08.034Search in Google Scholar

9. Sennhauser FH, Braun-Fahrlander C, Wildhaber JH. The burden of asthma in children: a European perspective. Paediatr Respir Rev 2005; 6:2–7.10.1016/j.prrv.2004.11.001Search in Google Scholar

10. Johansson SGO, Bennich H, Wide L. A new class of immunoglobulin in human serum. Immunology 1968; 14:265–72.Search in Google Scholar

11. Wide L, Bennich H, Johannson SGO. Diagnosis of allergy by an in-vitro test for allergen antibodies. Lancet 1967; 2:1105–7.10.1016/S0140-6736(67)90615-0Search in Google Scholar

12. van Ree R; CREATE Partnership. The CREATE project: EU support for the improvement of allergen standardization in Europe. Allergy 2004; 59:571–4.10.1111/j.1398-9995.2004.00499.xSearch in Google Scholar

13. Kazemi-Shirazi L, Niederberger V, Linhart B, Lidholm J, Kraft D, Valenta R. Recombinant marker allergens: diagnostic gatekeepers for the treatment of allergy. Int Arch Allergy Immunol 2002; 127:259–68.10.1159/000057742Search in Google Scholar

14. Chapman MD, Smith AM, Vailes LD, Arruda LK, Dhanaraj V, Pomes A. Recombinant allergens for diagnosis and therapy of allergic disease. J Allergy Clin Immunol 2000; 106:409–18.10.1067/mai.2000.109832Search in Google Scholar

15. Thomas WR, Smith W. Towards defining the full spectrum of important house dust mite allergens. Clin Exp Allergy 1999; 29:1583–7.10.1046/j.1365-2222.1999.00670.xSearch in Google Scholar

16. Niederberger V, Horak F, Vrtala S, Spitzauer S, Krauth MT, Valent P, et al. Vaccination with genetically engineered allergens prevents progression of allergic disease. Proc Natl Acad Sci USA 2004; 101(Suppl 2):14677–82.10.1073/pnas.0404735101Search in Google Scholar

17. Valenta R, Lidholm J, Niederberger V, Hayek B, Kraft D, Gronlund H. The recombinant allergen-based concept of component-resolved diagnostics and immunotherapy (CRD and CRIT). Clin Exp Allergy 1999; 29:896–904.10.1046/j.1365-2222.1999.00653.xSearch in Google Scholar

18. Schmid-Grendelmeier P, Holzmann D, Himly M, Weichel M, Tresch S, Ruckert B, et al. Native Art v 1 and recombinant Art v 1 are able to induce humoral and T cell-mediated in vitro and in vivo responses in mugwort allergy. J Allergy Clin Immunol 2003; 111:1328–36.10.1067/mai.2003.1495Search in Google Scholar

19. Deinhofer K, Sevcik H, Balic N, Harwanegg C, Hiller R, Rumpold H, et al. Microarrayed allergens for IgE profiling. Methods 2004; 32:249–54.10.1016/j.ymeth.2003.08.018Search in Google Scholar

20. Harwanegg C, Spitzauer S, Valenta R, Mueller MW, Hiller R. Protein biochips for the profiling of allergen-specific antibodies. In: Mark Schena, editor. Protein microarrays. Sudbury, MA (USA): Jones and Bartlett 2004, Chapter 13.Search in Google Scholar

21. Hantusch B, Scholl I, Harwanegg C, Krieger S, Becker WM, Spitzauer S, et al. Affinity determinations of purified IgE and IgG antibodies against the major pollen allergens Phl p 5a and Bet v 1a: discrepancy between IgE and IgG binding strength. Immunol Lett 2005; 97:81–9.10.1016/j.imlet.2004.10.002Search in Google Scholar

22. Harwanegg C, Laffer S, Hiller R, Mueller MW, Kraft D, Spitzauer S, et al. Microarrayed recombinant allergens for diagnosis of allergy. Clin Exp Allergy 2003; 33:7–13.10.1046/j.1365-2222.2003.01550.xSearch in Google Scholar

23. Mullenix MC, Wiltshire S, Shao W, Kitos G, Schweitzer B. Allergen-specific IgE detection on microarrays using rolling circle amplification: correlation with in vitro assays for serum IgE. Clin Chem 2001; 47:1926–9.10.1093/clinchem/47.10.1926Search in Google Scholar

24. Wiltshire S, O'Malley S, Lambert J, Kukanskis K, Edgar D, Kingsmore SF, et al. Detection of multiple allergen-specific IgEs on microarrays by immunoassay with rolling circle amplification. Clin Chem 2000; 46:1990–3.10.1093/clinchem/46.12.1990Search in Google Scholar

25. Kim TE, Park SW, Cho NY, Choi SY, Yong TS, Nahm BH, et al. Quantitative measurement of serum allergen-specific IgE on protein chip. Exp Mol Med 2002; 34:152–8.10.1038/emm.2002.22Search in Google Scholar

26. Hiller R, Laffer S, Harwanegg C, Huber M, Schmidt WM, Twardosz A, et al. Microarrayed allergen molecules: diagnostic gatekeepers for allergy treatment. FASEB J 2002; 16:414–6.10.1096/fj.01-0711fjeSearch in Google Scholar

27. Jahn-Schmid B, Harwanegg C, Hiller R, Bohle B, Ebner C, Scheiner O, et al. Allergen microarray: comparison of microarray using recombinant allergens with conventional diagnostic methods to detect allergen-specific serum immunoglobulin E. Clin Exp Allergy 2003; 33:1443–9.10.1046/j.1365-2222.2003.01784.xSearch in Google Scholar

Published Online: 2005-11-28
Published in Print: 2005-12-1

©2005 by Walter de Gruyter Berlin New York